Literature DB >> 1862685

Diabetic autonomic neuropathy.

M J Stevens1, P J Watkins.   

Abstract

One of the earliest manifestations of diabetic neuropathy is denervation of the cardiovascular system; loss of heart rate variability may have a prevalence as high as 21.5% in diabetic patients, and declines at 1 beat/min/year, which is 3 times faster than in normal subjects. The cause of this neuropathy is unknown: attempts at decreasing the excess quantities of sorbitol, glucose and fructose in nerve tissue have lead to little functional improvement in man. Nerve ischaemia and immunological damage have stimulated increased interest lately, the latter particularly because of the structural homology of nerve growth factor and insulin. Symptoms from autonomic neuropathy are rare. When present they may well be intermittent, but never remit; they rarely progress or become disabling. One uncommon consequente of loss of sympathetic vascular tone is postural hypotension. This may result from failure of splanchnic vasoconstriction on standing. Food and insulin can greatly exacerbate the postural blood pressure fall. Reduced vascular tone in the neuropathic foot leads to increased arterio-venous shunt flow. The local reflex control of this shunt flow is also abnormal: paradoxical vasoconstriction occurs in response to local skin heating and postural reflexes are reduced. This high shunt flow together with its abnormal vascular control may be important in the pathogenesis of neuroarthropathy and foot ulceration. The prognosis of patients with autonomic neuropathy is better than previously reported. Abnormal heart rate variability alone is of no prognostic value. The presence of symptoms, in particular postural hypotension, significantly reduces survival. The majority of deaths however, result from concurrent renal disease and macrovessel atheroma.

Entities:  

Mesh:

Year:  1991        PMID: 1862685     DOI: 10.1007/bf02732120

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  40 in total

Review 1.  Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves.

Authors:  A B Vallbo; K E Hagbarth; H E Torebjörk; B G Wallin
Journal:  Physiol Rev       Date:  1979-10       Impact factor: 37.312

2.  Blood flow in the diabetic neuropathic foot.

Authors:  M E Edmonds; V C Roberts; P J Watkins
Journal:  Diabetologia       Date:  1982-01       Impact factor: 10.122

3.  A new instrument for continuous measurement of tissue blood flow by light beating spectroscopy.

Authors:  G E Nilsson; T Tenland; P A Obert
Journal:  IEEE Trans Biomed Eng       Date:  1980-01       Impact factor: 4.538

4.  Cardiorespiratory arrest and diabetic autonomic neuropathy.

Authors:  M M Page; P J Watkins
Journal:  Lancet       Date:  1978-01-07       Impact factor: 79.321

5.  Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications.

Authors:  D J Ewing; I W Campbell; B F Clarke
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

Review 6.  Disorders of the autonomic nervous system: Part 2. Investigation and treatment.

Authors:  J G McLeod; R R Tuck
Journal:  Ann Neurol       Date:  1987-06       Impact factor: 10.422

7.  Sympathetic nerve failure in diabetes.

Authors:  P J Watkins; M E Edmonds
Journal:  Diabetologia       Date:  1983-08       Impact factor: 10.122

8.  Pathology of autonomic neuropathy in diabetes mellitus.

Authors:  L W Duchen; A Anjorin; P J Watkins; J D Mackay
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

9.  Oral supplementation of myoinositol: effects on peripheral nerve function in human diabetics and on the concentration in plasma, erythrocytes, urine and muscle tissue in human diabetics and normals.

Authors:  G Gregersen; B Bertelsen; H Harbo; E Larsen; J R Andersen; A Helles; M Schmiegelow; J E Christensen
Journal:  Acta Neurol Scand       Date:  1983-03       Impact factor: 3.209

10.  Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies.

Authors:  J Janssens; T L Peeters; G Vantrappen; J Tack; J L Urbain; M De Roo; E Muls; R Bouillon
Journal:  N Engl J Med       Date:  1990-04-12       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.